Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Hydroxyethyl Starch 130/0.4 and Electrolyte Injection

Approval Number

国药准字H20130006

Company北京费森尤斯卡比医药有限公司

Registration Date

August 18, 2022

Previous Approval Numbers

国药准字H20130006

Drug Information

Generic Name

羟乙基淀粉130/0.4电解质注射液

Brand Name

万衡

Dosage Form

注射剂（大容量注射剂）

Strength

500ml

Drug Type

化学药品

Registration Date

August 18, 2022

Company Information

Applicant Company

Company Name北京费森尤斯卡比医药有限公司

Company Address

北京市大兴区中关村科技园区大兴生物医药产业基地华佗路57号

Manufacturing Company

Company Name北京费森尤斯卡比医药有限公司

Company Address

北京市大兴区中关村科技园区大兴生物医药产业基地华佗路57号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy